H-CYTE, INC.·4

Apr 5, 7:45 PM ET

Horne William E 4

4 · H-CYTE, INC. · Filed Apr 5, 2021

Insider Transaction Report

Form 4
Period: 2021-04-01
Horne William E
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-04-01+2,000,0002,000,000 total
    Exercise: $0.07Exp: 2031-04-01Common Stock (2,000,000 underlying)
Footnotes (1)
  • [F1]On April 1, 2021, Hy-Cyte, Inc. (the "Company) issued to William E. Horne options (the "Options") to purchase 2,000,000 shares of the Company's common stock at an exercise price of $0.07. Beginning with the first fiscal quarter following the Grant Date, the Option Shares shall become exercisable in 12 equal quarterly installments of 250,000 Option Shares on the final day of each fiscal quarter, in each case, so long as the Grantee's service with the Company or a subsidiary is not interrupted or terminated on each such date.

Documents

1 file
  • 4
    ownership.xmlPrimary